POSTER SESSION IV & CONTINENTAL BREAKFAST

Wednesday, October 21, 2015: 7:30 AM - 9:00 AM
Grand Ballroom EH (Hyatt Regency St. Louis at the Arch)

PS4-1

DO ADVANCE DIRECTIVES YIELD DISPOSITIVE INFORMATION ABOUT TREATMENT PREFERENCES FOR INCAPACITATED, CRITICALLY ILL PATIENTS?
Jared Chiarchiaro, MD, Leslie Scheunemann, MD MPH, Natalie Ernecoff, MPH, Robert M. Arnold, MD and Douglas White, MD, MAS, University of Pittsburgh School of Medicine, Pittsburgh, PA
PS4-2

COST-EFFECTIVENESS ANALYSIS WITH MARKOV INFLUENCE DIAGRAMS
Francisco J. Díez, PhD1, Mar Yebra, MSc2, Iñigo Bermejo, MSc1, Miguel Ángel Palacios-Alonso3, Manuel Arias, PhD1, Manuel Luque, PhD1, Mark Sculpher, PhD4, Marta Soares, Msc4 and Claire Rothery, PhD4, (1)UNED, Madrid, Spain, (2)Technical University of Madrid, Pozuelo de Alarcón, Spain, (3)INAOE, Tonantzintla, Puebla, Mexico, (4)University of York, York, United Kingdom
PS4-4

THE VALUE OF TOTAL KNEE REPLACEMENT REVISITED: A COMPARATIVE ANALYSIS OF THE IMPACT OF INCREASED PROCEDURE RATES ON HEALTH OUTCOMES AND COSTS USING DATA FROM THE OSTEOARTHRITIS INITIATIVE
Zach Feldman, MSc1, Edwin Oei, MD, PhD2, Madhu Mazumdar, PhD3 and Bart Ferket, MD, PhD3, (1)Icahn School of Medicine at Mount Sinai, New York, NY, (2)Department of Radiology, Erasmus Medical Center, Rotterdam, Netherlands, (3)Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY
PS4-5

NEGATIVE-PRESSURE WOUND THERAPY (NPWT) EQUIPMENT IN THE MANAGEMENT OF OPEN ABDOMEN PATIENTS: COMPARISON BETWEEN TWO PAYMENT SCHEMES
Cecilia de la Luz Hipólito-Olivares, MSc and Leodegario Correa, Dr., Mexican Institute of Social Security-IMSS, Mexico City, Mexico
PS4-6

EXAMINING DISPARITIES IN THE TREATMENT AND COSTS OF KNEE OSTEOARTHRITIS USING AN INTERACTIVE MARKOV MODEL
Taruja Karmarkar, MHS1, Anne Maurer, MS2, Thomas Mason, MD3, Ana Eastman, MD4, Melvyn Harrington, MD5, Randall Morgan, MD, MBA6, Michael Parks, MD7 and Darrell Gaskin, PhD1, (1)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (2)Zimmer, Inc., Warsaw, IN, (3)Cook County Health & Hospitals System, Chicago, IL, (4)PIH Health, Whittier, CA, (5)Baylor College of Medicine Medical Center, Houston, TX, (6)W. Montague Cobb/NMA Health Institute, Washington, DC, (7)Hospital for Special Surgery, New York, NY
PS4-7

MEDICAL COST SAVINGS FROM MEDICATION ADHERENCE AND IMPLICATIONS FOR TARGETING BEHAVIORAL INTERVENTIONS
Steven Kymes, Ph.D., MHA1, Richard Pierce, Ph.D.1, Charmaine Girdish, MPH1, Olga Matlin, Ph.D.1 and William Shrank, MD, MSHS2, (1)CVS Health, Northbrook, IL, (2)CVS Health, Woonsocket, RI
PS4-8

COST-UTILITY ANALYSIS OF ORAL ANTISEPTIC CHLORHEXIDINE IN DECREASING VENTILATOR-ASSOCIATED PNEUMONIA IN INTENSIVE CARE UNITS
Sojung Lee, BSc, DDS1, Petros Pechlivanoglou, MSc, PhD2, Victoria McCredie, MBChB3, Carlos Quiñonez, DMD, MSc, PhD, FRCD(C)1, Murray D Krahn, MD, MSc, FRCPC2 and Amir Azarpazhooh, DDS, MSc, PhD, FRCD(C)1, (1)University of Toronto, Toronto, ON, Canada, (2)Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto, Toronto, ON, Canada, (3)Sunnybrook Health Sciences Center, Toronto, ON, Canada
PS4-9

THE VALUE OF QUALITY IMPROVEMENT INTERVENTIONS FOR CATHETER-ASSOCIATED URINARY AND BLOOD STREAM INFECTIONS: A SYSTEMATIC REVIEW
Teryl Nuckols, MD, MSHS1, Emmett Keeler, PhD1, Laura Anderson, MPH2, Brian Doyle, MD3, Aziza Arifkhanova,, MS1, Joshua Pevnick, MD, MSHS4, Kanaka Shetty, MD, MS1, Peggy Chen, MD, MSc, MHS1, Roberta Shanman, MS1, Jennifer Schneider Chafen, M.D., M.S.5, Margaret Maglione, MPP1, Courtney Coles, MPH6 and Paul Shekelle, MD, MPH, PhD7, (1)RAND, Santa Monica, CA, (2)UCLA School of Public Health, Department of Epidemiology, Los Angeles, CA, (3)UCLA Department of General Internal Medicine, Los Angeles, CA, (4)Cedars-Sinai Medical Center, Los Angeles, CA, (5)Castlight Health, San Francisco, CA, (6)UCLA School of Public Health, Department of Health Policy & Management, Los Angeles, CA, (7)VA Medical Center West Los Angeles, Los Angeles, CA
PS4-11

HEALTHCARE COSTS ATTRIBUTABLE TO LYME DISEASE: A POPULATION-BASED MATCHED COHORT STUDY IN ONTARIO, CANADA
Beate Sander1, Edwin Khoo, MPH1, John Wang, MSc1, Gerald Evans, MD2, Manon Fleury, MSc3, Stephen Moore, MPH1, Mark Nelder, PhD1, Nicholas Ogden, PhD3, Curtis Russell, PhD1, Doug Sider, MD, MSc1 and Samir Patel, PhD1, (1)Public Health Ontario, Toronto, ON, Canada, (2)Queens University, Kingston, ON, Canada, (3)Public Health Agency of Canada, Guelph, ON, Canada
PS4-12

ASSISTED REPRODUCTIVE TECHNOLOGIES (ARTS) IN ALBERTA, CANADA: AN ECONOMIC ANALYSIS TO INFORM POLICY DECISION-MAKING
Anil Vaidya, MBBS, MPH, MSc, Tania Stafinski, PhD, Alexa Nardelli, MPH, Tarek Motan, MD, MPH and Devidas Menon, MHS, PhD, University of Alberta, Edmonton, AB, Canada
PS4-13

ECONOMIC EVALUATION OF COMBINATION TREATMENTS – DOES USE OF NETWORK META-ANALYSIS MAKE A DIFFERENCE?
Torbjørn Wisløff, MSc, PhD, Oslo University Hospital & University of Oslo, Oslo, Norway
PS4-14

BARRIERS AND FACILITATORS OF IMPLEMENTING SHARED DECISION MAKING AND DECISION SUPPORT IN A PEDIATRIC HOSPITAL: A DESCRIPTIVE STUDY
Laura Boland, MSc, PhD(c), University of Ottawa, Institute of Population Health, Ottawa, ON, Canada, Daniel McIsaac, MD, MPH, FRCPC, The Ottawa Hospital, Ottawa, ON, Canada and Margaret L. Lawson, MD, MSc, FRCP, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada
PS4-15

NEWS ARTICLES ARE MORE LIKELY TO BE SHARED IF THEY COMBINE STATISTICS WITH EXPLANATION
David Broniatowski, PhD, The George Washington University, Washington, DC, Mark Dredze, PhD, Johns Hopkins University, Baltimore, MD and Karen Hilyard, PhD, University of Georgia College of Public Health, Athens, GA
PS4-16

PATIENT RESPONSE TO A DECISION SUPPORT TOOL IN DEVELOPMENT: VETERANS LIKE ME
Jorie Butler, PhD1, Bryan Gibson, PhD2, Lee Ellington, PhD3, Bruce Bray, MD4, Katherine Doyon3 and Qing Zeng, PhD4, (1)Center for Humanizing Critical Care, Intermountain Healthcare, Murray, UT, (2)SLC VA IDEAS Center of Innovation, Salt Lake City, UT, (3)University of Utah College of Nursing, Salt Lake City, UT, (4)University of Utah Biomedical Informatics, Salt Lake City, UT
PS4-18

PERFECTLY ACCOMPLISHED SHARED DECISION MAKING: A CALL TO CONSIDER A WIDER RANGE OF CONSEQUENCES
Dominick Frosch, PhD, Gordon and Betty Moore Foundation, Palo Alto, CA, Sarah Kobrin, PhD, MPH, National Cancer Institute, Bethesda, MD and Glyn Elwyn, MD, MSc, PhD, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH
PS4-19

EVALUATING A WORKSHOP TO DEVELOP SHARED DECISION MAKING AND DECISION COACHING SKILLS AMONGST PEDIATRIC HEALTHCARE PROFESSIONALS
Margaret L. Lawson, MD, MSc, FRCP1, Allyson L. Shephard, RN, MScN1, Jennifer Kryworuchko, PhD, RN, CNCC(C)2, Laura Boland, MSc, PhD(c)3, Janet Jull, OT, PhD1 and Dawn Stacey, RN, PhD, CON (C)4, (1)Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, (2)University of Saskatchewan College of Nursing, Saskatoon, SK, Canada, (3)University of Ottawa, Institute of Population Health, Ottawa, ON, Canada, (4)University of Ottawa, Ottawa, ON, Canada
PS4-21

INTEGRATING MENTAL HEALTH PATIENT DECISION AIDS INTO PRIMARY CARE PRACTICE
Felisha Marques, MPH, Karen Carlson, M.D., Lisa Brugnoli-Semeta, RN, Karen R. Sepucha, PhD and Leigh Simmons, M.D., Massachusetts General Hospital, Boston, MA
PS4-22

IMPORTANT FACTORS IN CLINICAL DECISION MAKING FOR RAPID STREPTOCOCCAL ANTIGEN TESTING: A SURVEY OF PEDIATRIC EMERGENCY DEPARTMENT (ED) PROVIDERS
Angela Myers, MD1, Russell McCulloh, MD2, Brian Lee2, Jennifer Goldman, MD2, Cameron Myers3, Sarah Weston, MD2 and Lisa Schroeder, MD2, (1)Children's Mercy Kansas City, Kansas City, MO, (2)Children's Mercy Hospital, Kansas City, MO, (3)University of Missouri Kansas City School of Medicine, Kansas City, MO
PS4-23

IMPLEMENTING COLLABORATE: A MEASURE OF SHARED DECISION MAKING
Paul Barr, PhD, Rachel Thompson, PhD, Rachel Forcino, Elissa M. Ozanne, PhD and Glyn Elwyn, MD, MSc, PhD, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH
PS4-24

PATIENT AND PROVIDER PERSPECTIVES ON SHARED DECISION-MAKING IN SYNCOPE: QUALITATIVE GROUNDWORK FOR DECISION-SUPPORT INTERVENTION DEVELOPMENT
Marc Probst, MD, MS1, Hemal Kanzaria, MD, MS2, Dominick L. Frosch, PhD3, Maggie Breslin, MDes4, Marie-noelle Langan, MD4, Erik Hess, MD, MSc5 and Lynne Richardson, MD1, (1)Mount Sinai, New York, NY, (2)Los Angeles, CA, (3)UCLA, Los Angeles, CA, (4)New York, NY, (5)Rochester, MN
PS4-25

OPTIMIZING THE USE OF MENTAL HEALTH DECISION AIDS IN THE OUTPATIENT SETTING
Karen R. Sepucha, PhD, Madeleine Matthiesen, MD, Felisha Marques, MPH, Lisa Brugnoli-Semeta, RN and Leigh Simmons, M.D., Massachusetts General Hospital, Boston, MA
PS4-26

PATIENT KNOWLEDGE AND PREFERENCES SURROUNDING INTERRUPTION OF ANTICOAGULATION THERAPY FOR MINOR PROCEDURES
Seema S. Sonnad, PhD, Christiana Care Health System Value Institute, Newark, DE, Debbi Chiappardi-Williams, RN, Christiana Care Health System, Newark, DE, Andrew Doorey, MD, Christiana Care Health System Cardiology Consultants, Newark, DE and Kimberly Williams, MPH, Value Institute, Christiana Care Health System, Newark, DE
PS4-27

OTTAWA DECISION SUPPORT TUTORIAL FOR ENHANCING UNDERSTANDING OF SHARED DECISION MAKING: WHAT DO THE USERS THINK?
Dawn Stacey, PhD1, Annette M. O'Connor, PhD1, Anton Saarimaki, MCS2 and Meg Carley, BSc2, (1)University of Ottawa, Ottawa, ON, Canada, (2)Ottawa Hospital Research Institute, Ottawa, ON, Canada
PS4-28

DEVELOPMENT OF A DECISION AID FOR PATIENTS WITH ADVANCED HEART FAILURE CONSIDERING A DESTINATION THERAPY LEFT VENTRICULAR ASSIST DEVICE
Jocelyn Thompson, MA1, Dan Matlock, MD, MPH2, Colleen McIlvennan, DNP, ANP3, Amy Jenkins, MS1 and Larry Allen, MD, MHS3, (1)University of Colorado School of Medicine, Adult and Child Center for Health Outcomes Research and Delivery Science, Aurora, CO, (2)The University of Colorado School of Medicine, Division of General Internal Medicine, Aurora, CO, (3)University of Colorado School of Medicine, Division of Cardiology, Aurora, CO
PS4-29

A WEB-BASED TUTORIAL TO PREVENT OBESITY GROUNDED IN FUZZY-TRACE THEORY IMPROVES KNOWLEDGE, GIST COMPREHENSION, AND HEALTHY VALUES
Valerie Reyna, PhD1, Priscila G. Brust-Renck, M.A., Ph.D1, Christopher R. Wolfe, Ph.D.2, Evan A. Wilhelms, M.S.1, Colin Widmer, M.A.2, Elizabeth Cedillos, M.A.2 and Anna Kate Morant, BSc1, (1)Cornell University, Ithaca, NY, (2)Miami University, Oxford, OH
PS4-31

NATION-WIDE ASSESSMENT OF INFORMED DECISION-MAKING IN PRENATAL SCREENING IN THE NETHERLANDS
Heleen M. E. van Agt, MSc, PhD1, Marleen M.H.J.D. Schoonen, MSc, PhD1, Jacques Fracheboud, MSc1, Jantine Wieringa, MSc2 and Harry J. de Koning, MD, PhD1, (1)Erasmus MC, University Medical Center, Rotterdam, Netherlands, (2)National Institute for Public Health and the Environment, Bilthoven, Netherlands
PS4-32

GRAPHICALLY SUMMARIZING RISK PREDICTION MODELS
Vanya Van Belle, PhD, Ir, ESAT-STADIUS / iMinds-KU Leuven Medical Information Technologies Department, KU Leuven, Leuven, Belgium and Ben Van Calster, PhD, KU Leuven Department of Development and Regeneration, Leuven, Belgium
PS4-33

DEVELOPMENT OF AN ONLINE PATIENT DECISION AID FOR PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Thomas LeBlanc, MD, MA1, David Rizzieri, MD2, Robert Wolf, PharmD3, Ellen Neylon, MSN, FNP-BC, RN, OCN4, Valerie Caroselli, PharmD5, Katie Deering, PharmD5 and Brad Schenkel, MS6, (1)Duke University School of Medicine, Durham, NC, (2)Duke University Medical Center, Durham, NC, (3)Mayo Clinic, Rochester, MN, (4)Center for Lymphoid Malignancies at Columbia University Medical Center, New York, NY, (5)EPI-Q, Inc., Oak Brook, IL, (6)Janssen Scientific Affairs, LLC, Horsham, PA
PS4-34

DECISION ANALYSIS IN THE TREATMENT PATHWAY FOR USE OF HYDROXUREA IN CHILDREN WITH SICKLE CELL DISEASE
Olubiyi Aworunse, MD MPH PhD(c), University of Texas School of Public Health Houston, Houston, TX and Sun-Young Kim, PhD, University of Texas School of Public Health, San Antonio, TX
PS4-35

ANTICOAGULATION FOR PREGNANT WOMEN WITH MECHANICAL HEART VALVES: A SYSTEMATIC REVIEW AND META-ANALYSIS
Rohan D'Souza1, Jackie Ostro1, Anne Malinowski1, Candice Silversides1, Mathew Sermer1, Kellie Murphy1, Beate Sander2, Prakesh Shah1 and Nadine Shehata1, (1)Mount Sinai Hospital, Toronto, ON, Canada, (2)Public Health Ontario, Toronto, ON, Canada
PS4-36

CHANGES IN PERFORMANCE IN THE HOSPITAL VALUE BASED PURCHASING PROGRAM AFTER THE ADDITION OF AN EFFICIENCY DOMAIN
Anup Das, BA1, Lena Chen, MD, MS2 and Edward Norton, PhD2, (1)University of Michigan, Ann Arbor, MI, (2)Ann Arbor, MI
PS4-37

THE "WORKING" DIAGNOSIS: CHANGES IN THE PNEUMONIA DIAGNOSIS AMONG HOSPITALIZED VETERANS
Barbara Jones, MD1, Makoto Jones, MD2, Zhou Xi3, Brian Sauer4, Brett South5, Qing Zeng-Treitler5, Wendy Chapman5 and Matthew Samore, MD6, (1)VHA Salt Lake City, University of Utah, and Intermountain Health Care, Salt Lake City, UT, (2)VHA Salt Lake CIty and University of Utah, Salt Lake City, UT, (3)SLC VA Health System & University of Utah, Salt Lake City, UT, (4)University of Uah, Salt Lake City, UT, (5)University of Utah, Salt Lake City, UT, (6)University of Utah, Salt Lake City, UT. VA Salt LAke City Health Care System, SLC, UT, Salt Lake City, UT
PS4-38

HEALTH ACTIVITY TRACKING IS ASSOCIATED WITH HIGHER MEDICATION ADHERENCE
Thomas Quisel, BS, Luca Foschini, PhD and Jessie Juusola, PhD, Evidation Health, Menlo Park, CA
PS4-39

DEVELOPMENT OF NEW HARM-BASED WEIGHTING APPROACH TO COMPOSITE INDICATORS: THE AGENCY FOR HEALTHCARE RESEARCH AND QUALITY PATIENT SAFETY FOR SELECTED INDICATORS (AHRQ PSI-90)
Kathryn M. McDonald, MM1, Halcyon Skinner, PhD, MPH2, Patricia Zrelak, PhD3, Garth Utter, MD3, Sheryl Davies, MA1, Hawre Jalal, PhD4, Robert Houchens, PhD5 and Patrick Romano, MD, MPH3, (1)Stanford University Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford, CA, (2)Truven Health, Ann Arbor, MI, (3)UC Davis, Sacramento, CA, (4)Department of Health Policy and Management, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, (5)Truven Health, Sacramento, CA
PS4-40

DEVELOPMENT OF MEDICAL IMAGING PATHWAYS FOR USE BY PRIMARY CARE PHYSICIANS
Ravi Menezes, PhD1, Lilly Whitham, MSc2, Jisla Mathews, MBBS, MBA2 and Karen Weiser, MBA2, (1)University Health Network, Toronto, ON, Canada, (2)Toronto, ON, Canada
PS4-41

GPS' CHOICE OF SERVICES IN A PUBLIC HEALTH CARE SYSTEM WITH FINANCIAL INCENTIVES
Andreas Pahle, MD, Bolteløkka Legesenter, Oslo, Norway, Daniel Sørli, MD, Sørumsand, Norway and Ivar Sønbø Kristiansen, Avdeling for helseledelse og helseøkonomi, Oslo, Norway
PS4-42

FACTORS AFFECTING THE DELIVERY OF A PHARMACIST-LED MEDICATION REVIEW. EVIDENCE FROM THE MEDSCHECK ANNUAL SERVICE IN ONTARIO
Petros Pechlivanoglou, MSc, PhD1, Lusine Abrahamyan, MD MPH PhD1, Linda Mackeigan, PhD2, Lisa Dolovich, PhD3, Giulia Consiglio, MSc2, Valeria E. Rac, MD, PhD1, Jonghyun Shin, MSc2, Suzanne Cadarette, MSc, PhD2 and Murray D Krahn, MD, MSc, FRCPC1, (1)Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto, Toronto, ON, Canada, (2)Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada, (3)Department of Family Medicine, McMaster University, Hamilton, ON, Canada, Hamilton, ON, Canada
PS4-43

EFFECT OF CORN PRICE ON MEAT CONSUMPTION AND HEALTH OUTCOMES IN BALTIMORE CITY
Allison Pitt, MS, Department of Management Science and Engineering, School of Engineering, Stanford University, Stanford, CA and Eran Bendavid, MD, MS, Stanford Health Policy, Centers for Health Policy and Primary Care and Outcomes Research, Department of Medicine, Stanford University, Stanford, CA
PS4-44

USE OF THE CHILD HEALTH UTILITY 9D INDEX IN AUSTRALIAN ADOLESCENTS WITH DENTAL CARIES
Utsana Tonmukayakul, DDS, MPH, MHEcon1, Hanny Calache, DDS, PhD2, Kerina Princi, BAppSc(Pod), GradDipHlthProm3 and Lisa Gold, MA, MSc, PhD1, (1)Deakin Health Economics, Melbourne, Australia, (2)Dental Health Services Victoria, Melbourne, Australia, (3)Australasian Leukaemia & Lymphoma Group, Melbourne, Australia
PS4-46

IMPLEMENTATION AND ADOPTION OF THE TELEHOMECARE PROGRAM FOR PATIENTS WITH HEART FAILURE OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Valeria E. Rac, MD, PhD1, Gemma Hunting, MA2, Nida Shahid, HBSc., CCRP1, Yeva Sahakyan, MD, MPH1, Iris Fan, BA2, Christelle Moneypenny, Hon BA, MSc (cand.)2, Aleksandra Stanimirovic, MSc, PhD (candidate)1, Taylor North2, Yelena Petrosyan, MD, MPH, PhD (Candidate)2 and Murray Krahn, MD, Msc, FRCPC2, (1)Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto, Toronto, ON, Canada, (2)Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada
PS4-47

IMPLEMENTING A MODEL OF ATTRIBUTE IDENTIFICATION USING CONTINUOUS STAKEHOLDER ENGAGEMENT TO PRIORITIZE TREATMENT DECISIONS FOR YOUTH WITH SERIOUS MENTAL AND COGNITIVE IMPAIRMENT
Susan dosReis, PhD1, Wendy Camelo Castillo, MD, PhD2, Melissa Ross, MA1, Marcy Fitz-Randolph, DO, MPH3, Angela Vaughn-Lee4 and Beverly Butler5, (1)University of Maryland School of Pharmacy, Baltimore, MD, (2)University of Maryland Baltimore, Baltimore, MD, (3)PatientsLikeMe, Cambridge, MA, (4)Maryland Coalition of Families, Baltimore, MD, (5)Timonium, MD
PS4-48

ENGAGEMENT OF MEMBERS OF MARGINALIZED POPULATIONS IN THE DEVELOPMENT OF PATIENT DECISION AIDS AND OTHER PATIENT-CENTERED TOOLS
Michèle Dugas, BA1, Gratianne Vaisson, MSc1, Thierry Provencher1, Érik Breton, PhD1, Selma Chipenda Dansokho, PhD1, Heather Colquhoun, PhD2, Angela Fagerlin, PhD3, Anik Giguère, PhD1, Sholom Glouberman, PhD4, Lynne Haslett, RN, NP, MEd5, Aubri S. Hoffman, PhD6, Noah Ivers, MD, PhD, CCFP7, France Legare, MD, PhD, CCFP1, Jean Legare8, Carrie A. Levin, PhD9, Karli Lopez, AA10, Victor M. Montori, MD, MSc11, Jean-Sébastien Renaud, PhD1, Kerri Sparling, BA12, Dawn Stacey, RN, PhD, CON (C)13, Marie-Ève Trottier, BA1, Robert J. Volk, PhD14, William Witteman, MISt15 and Holly O. Witteman, PhD1, (1)Université Laval, Quebec City, QC, Canada, (2)University of Toronto, Toronto, ON, Canada, (3)VA Ann Arbor Healthcare System & University of Michigan, Ann Arbor, MI, (4)Patients Canada, Toronto, ON, Canada, (5)East End Community Health Centre, Toronto, ON, Canada, (6)Geisel School of Medicine at Dartmouth College, Lebanon, NH, (7)Women's College Hospital, Toronto, ON, Canada, (8)Arthritis Society, Quebec, QC, Canada, (9)Informed Medical Decision Foundation, Healthwise, Boston, MA, (10)Stone Soup Group, Anchorage, AK, (11)Knowledge and Evaluation Research Unit - Mayo Clinic, Rochester, MN, (12)Six Until Me, East Greenwich, RI, (13)University of Ottawa, Ottawa, ON, Canada, (14)The University of Texas MD Anderson Cancer Center, Houston, TX, (15)CHU de Québec, Québec, QC, Canada
PS4-49

DEVELOPING A STATED-PREFERENCES INSTRUMENT FOR DUCHENNE/BECKER MUSCULAR DYSTROPHY– A COMMUNITY-ENGAGED RESEARCH APPLICATION
Ilene L. Hollin, MPH1, Caroline Young, ScM2, Caroline Hanson, BS1, Holly Peay, PhD, CGC2 and John F.P. Bridges, PhD1, (1)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (2)Parent Project Muscular Dystrophy, Hackensack, NJ
PS4-51

A STUDY OF PATIENT ENGAGEMENT IN THE CONTEXT OF DENTAL IMPLANTS
Ananthavalli Ramesh, B.E; M.S and Prakash Sai L, Ph. D, Indian Institute of Technology Madras, Chennai, India
PS4-52

PREFERENCE ELICITATION TO AID DECISION-MAKING FOR TREATMENT OF A FIRST TIME ANTERIOR SHOULDER DISLOCATION
Benjamin Streufert, MD1, Lori Orlando, MD1, Joel Huber, PhD2, Reed Johnson, PhD3, Dean Taylor, MD1, Shelby D. Reed, PhD3 and Richard Mather III, MD, MBA3, (1)Duke University Medical Center, Durham, NC, (2)Fuqua School of Business, Duke University, Durham, NC, (3)Duke Clinical Research Institute, Durham, NC
PS4-53

QUALITY OF REPORTING OF ABSTRACTS OF PEDIATRIC RANDOMIZED CONTROLLED TRIALS
Chelsea Koller, BS, Riley Hedin, David Herrmann, Michael Bibens, Sarah Kahn, Lauren Kollmorgen, Blake Umberham and Matt Vassar, PhD, Oklahoma State University Center for Health Sciences, Tulsa, OK
PS4-54

A DATA-GENERATED MARGIN-OF-ERROR TO DECIDE WHEN TWO MEASUREMENTS AGREE
Hongsheng Wu, PhD, Wentworth Institute of Technology, Boston, MA, Timothy Moore, MD, Department of Radiology at the University of Nebraska Medical Center, Omaha, NE, Alan Erickson, MD, Division of Rheumatology & Immunology University of Nebraska Medical Center, Omaha, NE and Robert Lew, PhD, Department of Veterans Affairs, Boston, MA
PS4-55

CAUSAL INFERENCE USING AGENT-BASED MODELS AND THE PARAMETRIC G-FORMULA
Eleanor Murray, ScD candidate1, James Robins, MD1, George R. Seage, DSc1, Kenneth Freedberg, MD, MSc2 and Miguel Hernan, MD1, (1)Harvard TH Chan School of Public Health, Boston, MA, (2)Massachusetts General Hospital, Boston, MA
PS4-56

LESS IS MORE – EQ-5D-5L VALUE SETS BASED ON AN 8-PARAMETER NON-LINEAR MODEL PREDICTS LEFT-OUT STATES BETTER THAN A 20-PARAMETER MAIN EFFECTS MODEL
Kim Rand-Hendriksen, PhD., Cand.Psychol1, Liv Ariane Augestad, MD, PhD1, Juan Manuel Ramos Goñi, Msc2 and Nan Luo, PhD3, (1)University of Oslo, Oslo, Norway, (2)EuroQol Research Foundation, 3068 AV Rotterdam, Netherlands, (3)Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
PS4-57

USING A HIDDEN MULTI-STATE MARKOV MODEL TO CHARACTERIZE UNOBSERVABLE DISEASE NATURAL HISTORY: THE CASE OF COLORECTAL CANCER RECURRENCE
Johnie Rose, MD, PhD1, Laura Homa, PhD2, Chung Yin Kong, PhD3, Neal J. Meropol, MD4, Michael W. Kattan, PhD5 and Gregory Cooper, MD4, (1)Case Western Reserve University School of Medicine; Case Comprehensive Cancer center, Cleveland, OH, (2)Case Western Reserve University School of Medicine, Cleveland, OH, (3)Massachusetts General Hospital - Institute for Technology Assessment, Boston, MA, (4)University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, (5)Cleveland Clinic, Cleveland, OH
PS4-58

USING REAL WORLD DATA TO STRUCTURE AND POPULATE MARKOV MODELS – A CASE STUDY OF TELEMONITORING FOR HEART FAILURE
Praveen Thokala, PhD, Pete Dodd, PhD, Simon Dixon, PhD and Alan Brennan, BSc, MSc, PhD, University of Sheffield, Sheffield, United Kingdom
PS4-59

A CALIBRATION HIERARCHY FOR RISK MODELS: ‘MODERATE' CALIBRATION GUARANTEES NON-HARMFUL DECISION MAKING
Ben Van Calster, PhD1, Daan Nieboer2 and Ewout W. Steyerberg, PhD2, (1)KU Leuven Department of Development and Regeneration, Leuven, Belgium, (2)Erasmus MC, University Medical Center, Department of Public Health, Rotterdam, Netherlands
PS4-60

THE QUALITY OF RESEARCH ABSTRACTS IN EMERGENCY MEDICINE
Laura Varney1, Byron Detweiler1, Alberto Chong1, Jonathan Holmes1, Ryan Johnston1, Michael Caniglia1, Bryan Gibson1 and Matt Vassar, PhD2, (1)Oklahoma State University College of Osteopathic Medicine, Tulsa, OK, (2)Oklahoma State University Center for Health Sciences, Tulsa, OK
See more of: 37th Annual Meeting of the Society for Medical Decision Making
<< Previous Session | Next Session >>